Search

Your search keyword '"Mycobacterium leprae physiology"' showing total 245 results

Search Constraints

Start Over You searched for: Descriptor "Mycobacterium leprae physiology" Remove constraint Descriptor: "Mycobacterium leprae physiology"
245 results on '"Mycobacterium leprae physiology"'

Search Results

1. Review of research progress on different modalities of Macrophage death in Mycobacterium leprae infection.

2. CYBB-Mediated Ferroptosis Associated with Immunosuppression in Mycobacterium leprae-Infected Monocyte-Derived Macrophages.

3. Mycobacterium leprae is able to infect adipocytes, inducing lipolysis and modulating the immune response.

4. Single-cell sequencing analysis reveals development and differentiation trajectory of Schwann cells manipulated by M. leprae.

5. Immunology of leprosy.

6. The expression of FOXP3 in lesions of several forms of leprosy in patients co-infected with HIV.

7. Leprosy in children in Cuba: Epidemiological and clinical description of 50 cases from 2012-2019.

8. Innovative tracking, active search and follow-up strategies for new leprosy cases in the female prison population.

9. Loop-mediated isothermal amplification (LAMP) assay targeting RLEP for detection of Mycobacterium leprae in leprosy patients.

10. Mycobacterium leprae transmission characteristics during the declining stages of leprosy incidence: A systematic review.

11. Mycobacterium leprae-helminth co-infections and vitamin D deficiency as potential risk factors for leprosy: A case-control study in south-eastern Brazil.

12. The function of peroxisome proliferator-activated receptors PPAR-γ and PPAR-δ in Mycobacterium leprae-induced foam cell formation in host macrophages.

13. Macrophage Polarization in Leprosy-HIV Co-infected Patients.

14. PGL-1 and LID-1 antibody levels in HIV-infected and HIV-uninfected individuals in a Hansen's disease (leprosy) endemic area of Brazil.

15. Myelin breakdown favours Mycobacterium leprae survival in Schwann cells.

16. Intracellular Mycobacterium leprae Utilizes Host Glucose as a Carbon Source in Schwann Cells.

17. Effectiveness of single-dose rifampicin after BCG vaccination to prevent leprosy in close contacts of patients with newly diagnosed leprosy: A cluster randomized controlled trial.

18. Mycobacterium leprae's evolution and environmental adaptation.

19. Cell Biology of Intracellular Adaptation of Mycobacterium leprae in the Peripheral Nervous System.

20. M. leprae interacts with the human epidermal keratinocytes, neonatal (HEKn) via the binding of laminin-5 with α-dystroglycan, integrin-β1, or -β4.

21. Life history tradeoffs in humans: increased life expectancy with sperm count reduction.

22. The effects of prednisolone treatment on serological responses and lipid profiles in Ethiopian leprosy patients with Erythema Nodosum Leprosum reactions.

23. Ticks as potential vectors of Mycobacterium leprae: Use of tick cell lines to culture the bacilli and generate transgenic strains.

24. Mycobacterium leprae Recombinant Antigen Induces High Expression of Multifunction T Lymphocytes and Is Promising as a Specific Vaccine for Leprosy.

25. Probing the structure-function relationship of Mycobacterium leprae HSP18 under different UV radiations.

26. Intrinsic activation of the vitamin D antimicrobial pathway by M. leprae infection is inhibited by type I IFN.

27. Vitamin D status contributes to the antimicrobial activity of macrophages against Mycobacterium leprae.

28. Autophagy Impairment Is Associated With Increased Inflammasome Activation and Reversal Reaction Development in Multibacillary Leprosy.

29. IL-37 and leprosy: A novel cytokine involved in the host response to Mycobacterium leprae infection.

30. Minimum requirements and optimal testing strategies of a diagnostic test for leprosy as a tool towards zero transmission: A modeling study.

31. Emerging Concepts of Adaptive Immunity in Leprosy.

32. BCG and Adverse Events in the Context of Leprosy.

33. Leprosy in Northwest Louisiana: A case series.

34. Clinical pilot study: Clarithromycin efficacy in multibacillary leprosy therapy.

35. Acute scrotum: Hansen's disease versus filariasis.

36. Innate Immune Responses in Leprosy.

37. Indoleamine 2,3-dioxygenase and iron are required for Mycobacterium leprae survival.

38. A Macrophage Response to Mycobacterium leprae Phenolic Glycolipid Initiates Nerve Damage in Leprosy.

39. Association of Nitric Oxide Synthase2 gene polymorphisms with leprosy reactions in northern Indian population.

40. Distinct Roles of Th17 and Th1 Cells in Inflammatory Responses Associated with the Presentation of Paucibacillary Leprosy and Leprosy Reactions.

41. The formation of lipid droplets favors intracellular Mycobacterium leprae survival in SW-10, non-myelinating Schwann cells.

42. Evaluation and Monitoring of Mycobacterium leprae Transmission in Household Contacts of Patients with Hansen's Disease in Colombia.

43. A Negative Feedback Loop Between Autophagy and Immune Responses in Mycobacterium leprae Infection.

44. A critical appraisal on pure neuritic leprosy from India after achieving WHO global target of leprosy elimination.

45. Corticosteroid therapy in borderline tuberculoid leprosy patients co-infected with HIV undergoing reversal reaction: a clinical study.

46. Pure or Primary neuritic Leprosy (PNL).

47. Non-exponential growth of Mycobacterium leprae Thai-53 strain cultured in vitro.

48. A case of leprosy in Malawi. Making the final push towards eradication: a clinical and public health perspective.

49. STING-Dependent 2'-5' Oligoadenylate Synthetase-Like Production Is Required for Intracellular Mycobacterium leprae Survival.

50. Pauci- and Multibacillary Leprosy: Two Distinct, Genetically Neglected Diseases.

Catalog

Books, media, physical & digital resources